ClinConnect ClinConnect Logo
Search / Trial NCT06466291

Spanish Wilson Disease Registry

Launched by ASOCIACIÓN ESPAÑOLA PARA EL ESTUDIO DEL HÍGADO · Jun 14, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Genetic Disease Registry Copper Wilson Disease

ClinConnect Summary

The Spanish Wilson Disease Registry is a study aimed at understanding Wilson Disease, a genetic condition that affects how the body processes copper. The main goal of this registry is to learn more about the current status of this disease in Spain. Researchers want to find out how many people have Wilson Disease and how often new cases occur. They will also look into various aspects of the disease, such as how it develops, how it is diagnosed, and what treatments work best. This information can help improve screening and diagnosis for patients in the future.

To participate in this study, individuals must have a confirmed diagnosis of Wilson Disease. The study is open to patients of all genders, typically aged 65 to 74, and they will need to provide their consent to join. Participants can expect to share information about their health, which will contribute to a better understanding of the disease and potentially lead to improved care for others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with a confirmed Wilson Disease diagnosis
  • Exclusion Criteria:
  • Refusal to sign the informed consent for the study

About Asociación Española Para El Estudio Del Hígado

The Asociación Española para el Estudio del Hígado (AEEH) is a prominent Spanish organization dedicated to advancing research and clinical practice related to liver diseases. Comprising a network of healthcare professionals, researchers, and advocates, the AEEH focuses on promoting education, fostering collaboration, and facilitating groundbreaking clinical trials aimed at improving patient outcomes. By supporting innovative studies and disseminating knowledge, the AEEH plays a critical role in enhancing the understanding and treatment of hepatic conditions, ultimately contributing to the advancement of liver health in Spain and beyond.

Locations

Barcelona, , Spain

Patients applied

0 patients applied

Trial Officials

Zoe Mariño

Study Director

Asociación Española para el Estudio del Hígado

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported